Related by context. All words. (Click for frequent words.) 76 Jean Pierre Sommadossi 72 Paul Laikind 72 Neil K. Warma 71 Joshua Boger Ph.D. 71 Edward Lanphier Sangamo 71 Prabhavathi Fernandes 71 Tuan Ha Ngoc 71 Barry Selick Threshold 70 Barry D. Quart 70 Adelene Q. Perkins 70 Daniel Junius 70 Georges Gemayel 70 Francois Nader 70 Howard H. Pien 70 Dino Dina 69 George J. Vergis 69 Carl A. Pelzel 69 Syndax 69 Jeffrey H. Buchalter 69 Kuslima Shogen Alfacell 69 Paolo Pucci chief 69 JJ Finkelstein 69 JJ Finkelstein RegeneRx 69 Ron Bentsur 69 Spiro Rombotis President 68 Fred Eshelman PPD 68 Alexis Borisy President 68 Fuad El Hibri 68 Rosen ViroPharma 68 Lonnie Moulder 68 Robert L. Bratzler 68 Elkan Gamzu Ph.D. 67 Kuslima Shogen 67 Ron Najafi 67 Mitchel Sayare 67 Keith Katkin 67 Gregory A. Demopulos 67 Safi Bahcall Ph.D. 67 Joanna Horobin MD 67 Thomas B. Okarma 66 George Scangos Ph.D. 66 MD Geron 66 Henri Termeer Genzyme 66 Zami Aberman 66 Thomas Mann Mediware 66 Philip Astley Sparke 66 Gerald T. Proehl 66 Matthew Emmens 66 Kim Blickenstaff Biosite 66 Elliott Sigal 66 Alton Boynton 66 Dr. Blobel 66 EnVivo Pharmaceuticals 66 Joshua Boger 66 Alnoor Shivji WaferGen 65 Norbert Bischofberger 65 Christoph Westphal MD Ph.D. 65 David Aviezer 65 Steven R. Deitcher 65 Charles Homcy MD 65 Mark Leuchtenberger 65 Timothy P. Walbert 65 Michael L. Kranda 65 stated Belinda Tsao 65 Dr. Aiping Young 65 Faheem Hasnain 65 Remi Barbier 65 Jeffrey Buchalter 65 James Manuso 65 Dr. Fahar Merchant 65 Barry Selick 65 Kleanthis G. Xanthopoulos Ph.D. 65 Moncef Slaoui 64 Kazumi Shiosaki 64 David Schenkein MD 64 Carl Spana Ph.D. 64 John Lechleiter Ph.D. 64 Michael H. Carrel 64 Dr. Scangos 64 Igor Gonda 64 Pedro Lichtinger 64 Yves Rosconi 64 Frank Karbe 64 Hank McKinnell Pfizer 64 Charlotte Keywood 64 QuatRx 64 Uli Hacksell Ph.D. 64 Kevin Rakin 64 Onno van de Stolpe 64 René Lerer MD 64 Dr. Rahul Singhvi 64 Maxine Gowen Ph.D. 64 Patrick J. Balthrop 64 Hoji Alimi 64 Dr. Kshitij Mohan 64 William Moffitt Nanosphere 64 Daniel Passeri Curis 64 Mohammad Azab MD 64 Thomas P. Koestler 64 Jeffrey M. Ostrove 63 Spiro Rombotis 63 commented Mitchel Sayare 63 Rahul Singhvi 63 Pierre Cassigneul president 63 Lars Ekman 63 NASDAQ AVEO 63 Bassil Dahiyat Ph.D. 63 Drew Fromkin President 63 Jinsheng Ren 63 Vincent Milano ViroPharma 63 Etubics 63 Edward M. Rudnic 63 Kevin Sharer Amgen 63 Armen PhD 63 Tragara Pharmaceuticals Inc. 63 Eran Broshy 63 Frank Baldino Jr. 63 Paolo Pucci 63 Gary F. Burbach 63 Hakan Edstrom 63 Sol J. Barer 63 Igor Gonda Ph.D. 63 Keith Katkin AVANIR 63 Mihael Polymeropoulos MD 63 Don deBethizy 63 Ken Cragun 63 Scott Pancoast Lpath 63 Mihael Polymeropoulos 63 Mr. Armando Anido 63 Dave Holveck 63 Garo H. 63 Iris Loew Friedrich 63 Carl Pelzel Depomed 63 Enanta Pharmaceuticals 63 June Almenoff MD 63 Leonard P. Shaykin 63 Herm Rosenman 63 Tarek Sherif chairman 63 John Maraganore Ph.D. 63 Francis Cuss 63 Errol De Souza 62 Lisa Krinsky 62 Yves Rosconi President 62 Tim Mayleben 62 Alexis Borisy 62 Ryo Kubota MD Ph.D. 62 Kevin Buehler Alcon 62 Harold Van Wart 62 Arthur Bedrosian president 62 Arnold Hantman 62 Ronald Brus 62 Cascade LifeSciences 62 William H. Rastetter 62 Anthony Giovinazzo 62 Randall Schatzman 62 Dan Passeri 62 Louis Drapeau 62 Martin Nicklasson 62 Donald L. Drakeman 62 L. Berns 62 Kathleen Danenberg 62 Aerovance 62 Christian Itin 62 Clay Siegall 62 Nasdaq IDRA today 62 Mark A. Sirgo 62 Jacob Inbar 62 Per Olof Andersson 62 Dr. Deborah Dunsire 62 Steven Ratoff 62 AVEO Pharmaceuticals 62 Jean Jacques Bienaime 62 Mr. Kriegsman 62 Arthur S. Przybyl 62 Theron E. Odlaug 62 Nancy Lurker 62 Celator Pharmaceuticals 62 Juergen Engel 62 Kirsten Drejer 62 Jim Sulat 62 Hollings Renton 62 THR beta agonist 62 Sheldon Berkle 62 Friedhelm Blobel 62 Peter A. Lankau 62 Tod Woolf Ph.D. 62 Judy C. Lewent 62 Nicole Onetto MD 61 novel anti infective 61 H. Kirn 61 Nicholas Nicolaides 61 midstage clinical 61 EnVivo 61 Dr. Manuso 61 Eric Rowinsky MD 61 Professor Silviu Itescu 61 Dave Marver 61 David Pernock 61 J. Mazzo Ph.D. 61 Candace Kendle PharmD 61 Deborah Rathjen 61 Vicente Anido Jr. 61 Mads Krogsgaard Thomsen 61 Dr. Hagop Kantarjian 61 Ph.D. Targacept 61 Prabhavathi Fernandes Ph.D. 61 Alan Colowick 61 Juergen Engel Ph.D. 61 Xytis 61 Mark Enyedy 61 TESARO 61 Ceregene 61 Patrick Balthrop 61 Joseph Feczko 61 ThromboGenics commenting 61 Christopher Anzalone Arrowhead 61 Yvonne Greenstreet 61 Claes Glassell 61 Antony Koblish 61 Sachiko Kuno Ph.D. 61 Najeeb Ghauri NetSol Technologies 61 Raymond T. Bartus 61 Arthur Nadata 61 BioNumerik 61 Duffy DuFresne 61 Paul Bisaro Watson 61 Bruce Cozadd 61 Steven Kriegsman 61 Jing Lou 61 Ms. Gerri Henwood 61 Oxxon 61 Steven A. Kriegsman 61 Haro Hartounian 61 CEQ# 61 Haim Aviv 61 Luc Mainville 61 Marc Cluzel 61 David P. Holveck 61 Gerold Bepler MD Ph.D. 61 Michael Kishbauch 60 George A. Scangos 60 Haro Hartounian Ph.D. 60 Tomas Leanderson 60 SinuNase ™ 60 FoldRx 60 Tod Woolf 60 Inc. NASDAQ EXEL 60 Jay Lichter 60 Omacetaxine 60 t2cure GmbH 60 Ph.D. XenoPort 60 Anna Gluskin 60 Don Kiepert 60 Nasdaq IDIX biopharmaceutical 60 Therion Biologics Corporation 60 Nancy Wysenski 60 Genitope Corporation 60 Staph Leavenworth Bakali 60 Glen de Vries 60 Patrick Fourteau 60 Ardea Biosciences 60 molecular chaperone regulation 60 Cerus Corporation 60 Caroline Dorsa 60 Daniel J. Abdun 60 Ivan Gergel MD 60 Celator 60 Gil Van Bokkelen 60 John H. Hammergren 60 Dr. Arndt Schottelius 60 Dale Pfost 60 PDX pralatrexate 60 Mpex 60 Yin Weidong 60 FoldRx Pharmaceuticals Inc. 60 Tarvacin TM 60 Venkat Jasti 60 Pascal Soriot 60 Vipin Garg 60 De Jager MD 60 Igeneon 60 Anat Cohen Dayag 60 Wolfgang Renner 60 forodesine 60 Per Olof Wallström 60 Thomas Lingelbach 60 T. Flavin 60 Cempra Pharmaceuticals 60 Clifford D. Nastas 60 novel therapeutic antibodies 60 Burt Adelman 60 Hoyoung Huh 60 Joseph K. Belanoff 60 IMiDs R 60 Howard Birndorf 60 Roger Perlmutter Amgen 60 Anders Ekblom 60 Glenn A. Oclassen 60 Agios Pharmaceuticals 60 Donna Ambrosino 60 Elliott Sigal MD Ph.D. 60 Francis DiNuzzo 60 Drew Fromkin 60 Semafore 60 Philippe Calais 60 Creabilis Therapeutics 60 Eckard Weber 60 Diatos 60 Tarek Sherif 60 Michael H. Tardugno 60 Tranzyme Pharma 60 Sigma Tau SpA 60 Selecta Biosciences 60 John R. Plachetka 60 H. Willard Flamel 60 Michele Garufi 60 Rene Lerer MD 60 Andrew Sculley eMagin 60 Dr. Marlies Sproll 60 William Freytag 60 Anthony J. Armini 60 Paul Barbas DPL 60 Blum Cytokinetics 60 Sidney Taurel chairman 60 Ludo Reynders 60 Dr. Masamichi Koike 60 NASDAQ INFI 60 Wolfgang Wein 60 Bernd Seizinger 60 David Wajsgras Raytheon 60 Arno Therapeutics 60 Trofex 60 Alan Kingsman 60 Pervasis 60 Frank Condella 60 Willard Dere MD 60 Dr. Gamzu 59 Chemokine Therapeutics 59 John Maraganore 59 Phase IIb clinical trials 59 Hedgehog antagonist 59 Thomas CK Yuen 59 Jens Schneider Mergener 59 Ryuji Ueno 59 Sidney Taurel Lilly 59 Matt Emmens 59 Mike Pickett Onvia 59 Pierre Cassigneul 59 Jai Nagarkatti 59 novel immunotherapies 59 Dani Bolognesi 59 Dr. Henrich Guntermann 59 Stephen Coggeshall 59 Craig Tooman 59 Dynogen 59 Joerg Reinhardt 59 Ulf Wiinberg 59 John Lechleiter Lilly 59 Gemin X 59 Nasdaq VRTX 59 Romil Bahl 59 Avila Therapeutics 59 TIMI Study Group 59 Armando Anido 59 Duncan Higgons 59 ANAVEX 59 Rashmi Barbhaiya 59 Mark Sirgo 59 Steven Shak 59 Kenneth I. Moch 59 Harold H. Shlevin 59 Bernard Poussot Wyeth 59 Nasdaq PGNX today 59 Catabasis 59 Elisabeth Lindner CEO 59 Clay B. Siegall 59 Nasdaq IDIX 59 Menelas Pangalos 59 PsychoGenics 59 Hybridon 59 FOLOTYN ® 59 oral antiviral 59 Receptos 59 immatics 59 Cardioxyl 59 Hoyoung Huh MD Ph.D. 59 Blane Walter 59 Ron Bentsur Chief Executive 59 Kelly Mann Mediware 59 Richard Faleschini 59 Philippe Archinard 59 Masafumi Nogimori 59 Patrice Milos 59 Metabasis Therapeutics Inc. 59 commented Alexis Borisy 59 Kumar Chandrasekaran 59 Mace Rothenberg 59 Andrew Uprichard 59 Ben Lipps 59 Michael V. Novinski 59 Anders Lonner 59 Inc. Nasdaq MLNM 59 Zosano 59 Genocea Biosciences 59 James Herbert Neogen 59 James Sapirstein 59 Nasdaq NPSP 59 James Heppelmann 59 Salmedix 59 initiated Phase 1b 59 John M. Radak 59 Hacksell 59 Amir Avniel 59 Dr. Stylli 59 Genaera Corporation 59 Nasdaq FURX 59 Pramod Bhasin Genpact 59 SciClone Pharmaceuticals 59 Walt Havenstein SAIC 59 Tadataka Yamada 59 Mark Leuchtenberger President 59 Gideon Mantel Commtouch 59 AVN# [001] 59 GVAX ® 59 Resolvyx 59 KaloBios 59 VentiRx 59 Phase Ib II 59 Greg Lucier Invitrogen 59 trastuzumab DM1 T DM1 59 NovaBay Pharmaceuticals 59 Surfaxin LS 59 Al Altomari 59 Frank Verwiel MD 59 Jan Turek Biolex 59 Marijn E. Dekkers 59 therapeutic monoclonal antibody 59 Inc. NASDAQ SNUS 59 TOPIGEN 59 Mark Emkjer 59 Richard Garr Neuralstem 59 Hank Nordhoff 59 isoform selective 59 J. Donald deBethizy 59 Paul Stoffels 59 Immunex Corporation 59 NASDAQ PCYC 59 Roland Haefeli 59 Trofex TM 59 Stanley Crooke 58 Marc Tessier Lavigne 58 seliciclib CYC# 58 Ken Dahlberg SAIC 58 Craig Sturken Spartan 58 James SJ Manuso 58 Daniel Vasella Chairman 58 Wayne T. Hockmeyer 58 Wayne Koff 58 Ralph Makar 58 Dr. Joseph Feczko 58 Hans Joachim Lohrisch 58 adrenergic regulation 58 Aron Ain Kronos 58 TRACON Pharmaceuticals 58 Kosan dependence 58 Justus Homburg 58 Bradbury Amylin 58 Conatus Pharmaceuticals 58 Loïc Maurel MD 58 Joern Aldag President 58 phase IIa clinical 58 Mark Pykett 58 Dennis Gillings 58 Cary Rayment Alcon 58 NeuroMedix 58 Vaughn M. Kailian 58 Brian Markison 58 Inc. Nasdaq AFFY 58 Elmar Schnee 58 Steven B. Ratoff 58 Jean Luc Belingard 58 Andrew Guggenhime 58 Roger Perlmutter 58 HQK 58 Elliot Sigal 58 PharmD Ardea 58 Armando Anido Chief Executive 58 deforolimus 58 Thomas Okarma Geron 58 KRYSTEXXA TM pegloticase 58 Vance Vanier 58 Jack Abuhoff 58 Calistoga Pharmaceuticals 58 John C. Ruckdeschel 58 Avtar Dhillon MD 58 Prof. Pnina Fishman 58 Jeffrey M. Yordon 58 HCV antiviral 58 Chimigen TM 58 obatoclax 58 Jeffrey Kindler Pfizer 58 XTLbio 58 CRMD# 58 Richard J. Meelia 58 Amicus Therapeutics Nasdaq FOLD 58 Anthony Storino senior 58 Stevan Jovanovich 58 OTC BB PVCT 58 Intarcia Therapeutics 58 Neogenix 58 Jerry Selitto 58 AviaraDx 58 Inc. Nasdaq IMGN 58 Regado Biosciences 58 PEG SN# 58 CCR5 mAb 58 Progenics Pharmaceuticals 58 KNS # 58 Alexei Marko 58 antisense therapeutics 58 please visit http:/www.vandapharma.com 58 Ulrich Dauer CEO 58 IMiDs ® compound 58 Ms. Momoko Beran 58 ZFP Therapeutics 58 Gerd Zettlmeissl 58 Candace Kendle 58 Dr. Lorne Tyrrell 58 Dick Hipple 58 Alnoor Shivji 58 Nasdaq ENZN 58 Martin Gerstel 58 Scott Tarriff 58 Rob Rueckl 58 initiated Phase Ib 58 apricitabine ATC 58 Najeeb Ghauri NetSol 58 Enzon Pharmaceuticals 58 Inc. NASDAQ HEPH 58 Safi Bahcall 58 Peter Blackmore UTStarcom 58 Laura Brege 58 Urocortin 2 58 Joseph Rubinfeld 58 Dr. Joerg Reinhardt 58 Eric L. Dobmeier 58 Terje Storeng Odfjell 58 JP Fingado president 58 novel peptides 58 GENR 58 Christine Dingivan MD 58 ThermoDox ® clinical 58 John F. Thero 58 Intarcia 58 Jeremy Curnock Cook 58 Sylvie Gregoire 58 Orville G. Kolterman 58 Galenea 58 oncolytic virus therapies 58 Chemophase 58 CeNeRx BioPharma 58 Kleanthis Xanthopoulos 57 Roger Boissonneault 57 Fereydoun Firouz 57 Rod McGeary 57 Aegerion 57 Henry F. Blissenbach 57 Anadys Pharmaceuticals 57 Weidong Yin 57 Staph Bakali 57 Nasdaq AGEN 57 Garo Armen 57 Swisher Sunesis 57 Thomas C. Freyman 57 Inc. NASDAQ ORXE 57 NP2 Enkephalin 57 Dr. Horst Zerbe 57 Ziopharm 57 MacroChem Corporation 57 talactoferrin 57 CCR9 antagonist 57 Dr. Boro Dropulic 57 Wellstat 57 alvespimycin 57 novel immunomodulatory 57 Martin Madaus Millipore 57 Poniard Pharmaceuticals 57 Ursula Ney 57 Stuart Essig Integra 57 Michael Fonstein 57 Barry Labinger 57 rALLy clinical trial 57 Idera Pharmaceuticals 57 NASDAQ CLSN 57 Pascal Pfister 57 Joseph Feczko Pfizer 57 Nasdaq RXII 57 Ellen Strahlman 57 Peer Schatz QIAGEN 57 Ceflatonin R 57 Charlesson 57 Pervasis Therapeutics Inc. 57 Stafford O'Kelly 57 Fran DiNuzzo 57 David Sidransky MD 57 Maurizio Fava MD 57 Michele Garufi Chairman 57 Bill DeLaney Sysco 57 Lauren Silvernail 57 Richard Treagus 57 George Scangos 57 Daniel O. Wilds 57 Panzem R 57 Peer Schatz 57 Torbjörn Bjerke 57 Dr. Bassam Damaj 57 FluoroPharma 57 Merrimack Pharmaceuticals 57 Phase 1b clinical trials 57 Adrian Hobden 57 Zeb Horowitz 57 Archexin 57 Lance Rosenzweig PeopleSupport 57 Phase 1b trial 57 Alvine Pharmaceuticals 57 Maxine Gowen 57 Jack Lief 57 Daniel Von Hoff 57 Clive Meanwell 57 PDE4 inhibitor 57 Marillion Pharmaceuticals 57 M. Bradbury Amylin 57 Chief Executive Franz Humer 57 Jean Luc Bélingard Chairman 57 Andreas Barner 57 Diane S. Goostree 57 Meritage Pharma 57 MBRX 57 Mark HN Corrigan 57 Paolo Paoletti 57 NASDAQ VRTX 57 Advanced Biotherapy 57 Antony Koblish President 57 John A. Kraeutler 57 Noscira 57 Werner Cautreels 57 Robert J. Capetola 57 Inotek 57 commented Nicholas Landekic 57 Nikki Shindo 57 Louise Makin 57 Patrik De Haes 57 visit www.sciclone.com 57 Nancy Simonian 57 Vincent Mutel CEO 57 Epiphany Biosciences 57 Idun Pharmaceuticals 57 Dicerna 57 Timothy P. Clackson 57 Phytomedics Inc. 57 Amarantus 57 R MSCRAMM 57 VasoGenix Pharmaceuticals 57 NASDAQ LIPD 57 please visit www.dyax.com 57 vaccines oncolytic virus 57 Andy Boorn 57 investigational HCV polymerase 57 Jack Lief Arena 57 Carl Pelzel 57 Robin Stracey 57 Hem Pandya 57 Tom Gerke EMBARQ 57 Alex Kotzer 57 cardio renal 57 Neil Flanzraich vice 57 Gerri Henwood 57 phase Ib 57 LibiGel ® 57 Mark G. Foletta 57 Al Luderer Ph.D. 57 Marc Chardon Blackbaud 57 multicenter Phase II 57 Nasdaq PARS 57 tumor immunology 57 preclinically 57 InteKrin 57 Joshua Schein 57 Dr. Kai Lindevall 57 Emisphere Technologies 57 thiazolides 57 Syntonix 57 ALN VSP 57 Aflibercept 57 PNT# 57 Therapeutic Competitors companiesandmarkets.com adEgemonye 57 Mpex Pharmaceuticals 57 Dr. Sidransky 57 Mary Tagliaferri 57 Dr. Randall Yatscoff 57 Panzem 57 GRN# 57 NASDAQ CYTO 57 TELINTRA R 57 Howard Pien Chiron 57 ViiV Healthcare 57 Elkan Gamzu 57 Melior Discovery 57 Norbert Riedel 57 W. Pascoe Somaxon 57 Ception Therapeutics 57 Phase Ib study 57 Daniel Tasse 57 Curaxin 57 SGX Pharmaceuticals 57 Bernard Poussot 57 AMEX ISV 57 Entropin 57 Dr. Othmar Pfannes 57 George Migausky 57 TNFerade ™ 57 personalized cellular immunotherapy 57 Roy Vallee Avnet 57 oral prodrug 57 William Slichenmyer MD Sc.M. 57 GlycoMimetics 57 Deborah Dunsire 57 Tony Milici 57 romazarit 57 Alzhemed TM 57 Veronate R 57 Yaffa Beck 57 Pathway Diagnostics 57 Steven Sterin senior 57 Radu Leca 57 Dr. Kobi Vortman 57 CYT# vascular disrupting 57 John Langstaff Cangene 57 Dr. Avtar Dhillon 57 Dr. Philip Toleikis 57 Christoph Westphal 57 David Tsur 57 Mr. Bienaime 57 Cara Therapeutics 56 Shai Gozani 56 OTCBB NRGX 56 NormOxys 56 Begins Dosing 56 Sudhir Agrawal D.Phil 56 EGEN 56 DPX Survivac 56 HCD# [002] 56 David Sidransky 56 Aphton Corporation 56 Dennis Podlesak 56 Emilio Emini 56 oral picoplatin 56 NASDAQ SLXP today 56 Quinamed 56 Cerimon 56 YONDELIS 56 Tom van Aken 56 Arete Therapeutics 56 Romidepsin 56 Cyclacel Pharmaceuticals 56 Proacta 56 Numoda 56 PNP inhibitor 56 Innovive Pharmaceuticals 56 ongoing Phase IIIb 56 WILEX 56 Unither Pharmaceuticals 56 Masayo Tada 56 RGB # 56 KAI Pharmaceuticals 56 epigenetic therapies 56 J. DeLuccia 56 Addrenex 56 Kemal Malik 56 Arcxis Biotechnologies 56 OvaRex 56 Ventaira Pharmaceuticals 56 candidate REP# 56 Karin Eastham 56 Xcytrin R 56 Logical Therapeutics 56 Ron Rittenmeyer EDS 56 Relypsa 56 vosaroxin 56 Chang Ahn Rexahn 56 Amplimmune 56 Kevin Buchi 56 Adventrx 56 Vitaxin 56 Emer Leahy 56 Patrick Schwarz Schuette 56 Martin Nicklasson CEO 56 YONDELIS R 56 NASDAQ ABII 56 Adolor Corporation 56 VIA Pharmaceuticals 56 VitiGam 56 NASDAQ ARRY 56 Allovectin 7 56 Walter Alessandrini 56 Protexia ® 56 NASDAQ SNTA 56 PORxin TM 56 Syndax Pharmaceuticals 56 oncology rheumatology 56 Phase #b/#a 56 Joseph Scodari 56 Zenvia ™ 56 Constantine Deno Macricostas Photronics 56 symbol AVXL 56 Peregrine Pharmaceuticals 56 NASDAQ IDRA 56 HDL Mimetic Peptide 56 Nuon Therapeutics 56 Sirion Therapeutics 56 Aurexis 56 BiTE R 56 Jerre Stead IHS 56 Marqibo TM 56 Optimer Pharmaceuticals 56 Palatin Technologies 56 Dr. Ellen Strahlman 56 CR# vcMMAE 56 Bruce Galton 56 SMT C# 56 Vaccinex 56 Abbas Mohaddes 56 KuDOS 56 ALN PCS 56 Addrenex Pharmaceuticals 56 Jay Grinney HealthSouth 56 AVEO Pharmaceuticals Inc. 56 ALTROPANE R 56 PRTX 56 Robert D. Daleo 56 Visit www.BASInc.com 56 Dr. Damaj 56 Nicholas Landekic 56 Tikvah Therapeutics 56 Ira L. Goldknopf 56 Jim Mulva chairman 56 Albert Luderer 56 J. Melamede 56 André Michel Ballester 56 Dennis Gillings CBE 56 anticoagulant reversing agent 56 Trubion Pharmaceuticals TRBN 56 NASDAQ AEZS TSX AEZ 56 Jennerex 56 Phil Pead 56 Roubik Gregorian 56 Adnan Mjalli 56 Jal S. Jassawalla 56 Phase 1a clinical 56 ARQL 56 Procyon Biopharma 56 Sulonex TM 56 NeoGenesis 56 diabetes irritable bowel 56 Exherin TM 56 Steven D. Skolsky 56 Ocrelizumab 56 BioFocus DPI Galapagos 56 Eric Bjerkholt 56 Leiden MD Ph.D. 56 Edward F. Voboril 56 David Bupp Neoprobe 56 Applied NeuroSolutions 56 Bayhill Therapeutics 56 MD Ph.D. Kosan 56 Anders Hedegaard 56 Fischer GenVec 56 Pfizer Regenerative Medicine 56 Metabasis Therapeutics 56 Bernard Pecoul 56 Neose Technologies 56 Vion Pharmaceuticals 56 Dr. Mazanet 56 CRLX# 56 Jean Loup Romet 56 Gemin X Biotechnologies 56 Ed Harbach 56 Lars Kongsbak 56 Metabasis Therapeutics Nasdaq MBRX 56 HGS# 56 Tim Steinkopf 56 Nasdaq DYAX 56 Rob Cascella President 56 Opexa 56 Erich Hunziker 56 Harry Debes Lawson 56 Sven Andreasson 56 Daniel M. Skovronsky 56 hepatitis C polymerase inhibitor 56 biomarkers predictive 56 Nasdaq DVAX 56 Peptimmune 56 B. Lynne Parshall 56 Altair Therapeutics 56 TransMolecular 56 TetraLogic 56 website www.celsion.com 56 Lexicon Pharmaceuticals 56 Cylene Pharmaceuticals 56 HCV nucleotide polymerase inhibitor 56 Jean Pierre Lehner 56 Don Wellendorf chief 56 Dr. Emilio Emini 56 midstage trials 56 Alnara 56 Elusys 56 M.D. Ph.D. 56 non nucleoside inhibitor 56 Orville Kolterman 56 Phase #b/#a clinical 56 Tranzyme 56 IMA# 56 Source MDx 56 Dana Kammersgard 56 SIX RO ROG 56 Dr. LaMattina 56 Kevin Hrusovsky President 56 Sol Barer 56 Greg Geissman 56 registrational trials 56 tubulin inhibitor 56 Cloretazine 56 leading oral taxane 56 Dr. Cauwenbergh 56 Preclinical Development 56 Nasdaq IMGN 56 Jean Stéphenne 56 AngioChem 56 IRX Therapeutics 56 ViroStatics 56 Derek Hennecke 56 MKC# MKC# PP 56 Ajay Banga MasterCard 56 James S. Manuso 56 non nucleoside polymerase 56 velafermin 56 Cardean Learning Group 56 AlgoRx 56 Jeff Morhet Chairman 55 metaglidasen 55 Dennis Rediker 55 Craig Tuttle Transgenomic 55 Phase Ib clinical 55 Nitric Bio 55 Nasdaq SGMO announced 55 Jack Kraeutler 55 generation URAT1 inhibitor 55 Ardea Biosciences Inc. 55 CEO Sidney Taurel 55 JAK inhibitor 55 representing upland cotton 55 John Hlywak 55 Sunesis Pharmaceuticals 55 website http:/www.celsion.com 55 Nereus Pharmaceuticals 55 ATG Fresenius S 55 Inc. Nasdaq AVRX 55 Tibotec BVBA 55 ILEX Oncology 55 Memryte 55 Sutro Biopharma 55 telomerase inhibitor drug 55 Hana Biosciences 55 Anders Essen Moller 55 Campath ® 55 Nasdaq INCY announced 55 including eniluracil ADH 55 please visit http:/www.atherogenics.com 55 Naglazyme R 55 PORxin TM platforms 55 Medivation Inc 55 Ph.D. Sucampo Pharmaceuticals 55 MacuSight 55 IL# PE#QQR 55 BrachySil TM 55 Scott Huennekens 55 Roch Doliveux 55 Annamycin 55 Hartmut Ehrlich MD 55 Tacere 55 Casper Zublin Jr. 55 oral Azacitidine 55 Nasdaq ONXX 55 Nasdaq AVNR 55 Thomas R. Watjen 55 SUCCEED trial 55 CRMD pharmaceutical 55 Personalized Immunotherapy 55 Steve Oldham SureWest